Evidence so far demonstrates that GLP-1 agonists can produce unprecedented results for people trying to achieve weight loss, in some cases enabling patients to lose 15-20% of their body weighttwo to three times the amount achieved with previous medications
As we continue to learn more about the gut-brain axis, metabolic inflammation, and the overall biology that drives obesity, drugs like tirzepatide could change the landscape of diabetes treatment, obesity medicine, and chronic metabolic disease for patients around the globe
Ian Neeland, Director, Center for Cardiovascular Prevention, Harrington Heart and Vascular Institute at University Hospitals in Cleveland and the McCamon Family Chair in Cardiovascular Excellence
| What are the side effects
What is Mounjaro used for
Short Answer There is no scientific difference in absorption or weight loss efficacy between the approved injection sites